Preclinical - Blog Archives

Blog

Pharmacometricians can use machine learning for PK/PD modeling to help them characterize the safety and…

CertaraMarch 4, 2025

Blog

February 28, 2025 For the past couple of decades, leading American institutions, pharmaceutical and biotechnology…

CertaraFebruary 28, 2025

Blog

February 24, 2025 Efficient drug development relies on informed decision-making. For toxicologists, having timely access…

CertaraFebruary 24, 2025

Blog

February 7, 2025A key drug development safety consideration is whether the drug candidate will interact…

CertaraFebruary 7, 2025

Blog

December 5, 2024 What is a “cell therapy”? Nearly every recent oncology clinical conference has…

CertaraDecember 5, 2024

Blog

Physiologically-based pharmacokinetic modeling can be used to support bioequivalence (BE) assessment of complex and locally…

CertaraNovember 12, 2024

Blog

Welcome to the forefront of drug development innovation! The drug development landscape is rapidly evolving,…

CertaraJune 4, 2024

Blog

The Phoenix UGM featured industry expert insights, peer networking, and glimpses into the latest PK/PD…

CertaraMay 31, 2024

Preclinical – Blog